MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/13872877261469118

Медицинская библиотека · Journal of Alzheimer's disease : JAD · 2026

Impact of SARS-CoV-2 infection on the progression of Alzheimer's disease: A prospective cohort study.

Qiu Jiating, Zhang Yishu, Shang Yajun, Shang Qunzhu, Li Lu, Chen Yili, Dai Shujuan, Ai Mingda, Xi Xiaoting, Huang Wei, Zhang Junyan, Liu Xiaolei

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BackgroundSARS-CoV-2 infection is associated with neurological sequelae and may accelerate Alzheimer's disease (AD) progression through neuroinflammation and protein aggregation. However, longitudinal evidence regarding the cognitive impact of COVID-19 in patients with AD remains scarce, and this interaction requires further clarification.ObjectiveTo explore whether COVID-19 accelerates cognitive decline in patients with AD.MethodsA total of 120 participants were enrolled, including 63 in the COVID-19 group and 57 in the non-COVID-19 group. The primary outcomes were disease decline and disease deterioration over three months, assessed using CDR-SB. Disease deterioration indicated clinically meaningful worsening, whereas disease decline captured subtler progression. Multivariable logistic regression adjusted for demographic, clinical, lifestyle, genetic, and disease severity factors. Overlap-Weighted Propensity Score Matching was additionally performed to reduce confounding during the 3-month follow-up.ResultsCOVID-19 significantly increased the risk of disease decline (OR = 10.39, 95% CI:3.87 to 27.87, p < 0.001) and disease deterioration (OR = 10.37, 95% CI: 2.71 to 39.65, p = 0.001). APOE ε4 carrier status was associated with a higher risk of deterioration (OR = 1.72), while those with unknown APOE status exhibited an even greater risk (OR = 5.20, 95% CI:1.32 to 20.53, p = 0.019). Secondary analyses confirmed that COVID-19 patients experienced significantly greater increases in CDR-SB scores compared to non-COVID-19 patients.ConclusionsSARS-CoV-2 infection was associated with greater short-term cognitive worsening over a three-month period in patients with AD, underscoring its potential public health relevance and the need for early surveillance to guide timely clinical management.

Для цитирования: Qiu Jiating, Zhang Yishu, Shang Yajun, Shang Qunzhu, Li Lu, Chen Yili, Dai Shujuan, Ai Mingda, Xi Xiaoting, Huang Wei, Zhang Junyan, Liu Xiaolei. Impact of SARS-CoV-2 infection on the progression of Alzheimer's disease: A prospective cohort study.. Journal of Alzheimer's disease : JAD. 2026. DOI: 10.1177/13872877261469118.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.